Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/19/1999US5968932 Method of inhibiting sleep apnea
10/19/1999US5968931 Taxoids, preparation thereof and pharmaceutical compositions containing same
10/19/1999US5968930 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
10/19/1999US5968926 Schizophrenia treatment with 1,2,5-oxadiazole or 1,2,5-thiadiazole
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968922 Gallium complexes of 3-hydroxy-4-pyrones to treat or prevent hypercalcemia
10/19/1999US5968921 Compositions and methods for promoting nerve regeneration
10/19/1999US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/19/1999US5968919 Hormone replacement therapy drug formulations for topical application to the skin
10/19/1999US5968918 Method for the prevention of coronary artery spasm
10/19/1999US5968917 Composition for prevention and treatment of osteoporosis comprising diosgenin, vitamin k, vitamin d
10/19/1999US5968914 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
10/19/1999US5968913 Pharmaceutical compositions of uridine triphosphate
10/19/1999US5968911 Administering nitric oxide precursors or derivatives, phosphodiesterase inhibitors or cyclic nucleotides into trachea or bronchi in aerosol form
10/19/1999US5968910 Two or three compounds which do not select for same mutantstrains; preventtion or treatment of htlv infections
10/19/1999US5968909 Method of modulating gene expression with reduced immunostimulatory response
10/19/1999US5968907 1-thiogalactose derivatives
10/19/1999US5968906 Sucralfate preparations
10/19/1999US5968900 Increasing blood plasma concentrations and muscle storage by administering mixtures of creatine and carbohydrates, also a simultaneous increase in blood insulin concentration
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968825 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene
10/19/1999US5968821 Adenovirus vector containing nucleotide sequence coding polypeptide which binds and inhibits cyclin kinase; screening for agonist or antagonist to cell propagation; develop immunogen; antitumor agents; diagnostic model for disease
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968818 Nucleic acid coding an enzyme whose presence can be used to acess sensitivity to atherosclerosis
10/19/1999US5968809 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968770 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968734 Dna sequences that migrate to new genetic positions and the fusion products; diagnosis of carcinomas, melanomas, and sarcomas suchas ewing's sarcoma
10/19/1999US5968727 Solution for long term preservation of transplantable organs deprived of oxygen
10/19/1999US5968726 Blood substitute of aqueous solution of hydroxyethyl starch, simple sugar, dynamic buffer, sodium ions, chloride ions, magnesium ions, potassium ions, and calcium ions; with subphysiological concentrations of potassium; autoclavable
10/19/1999US5968567 Method of preparing a food product from cruciferous sprouts
10/19/1999US5968553 Storage stability, shelf life
10/19/1999US5968552 Oral drug as antagonist for cardiovascular disorders for time release agents
10/19/1999US5968551 Sustained release analgesics; bioavailibility
10/19/1999US5968548 Use of liposome encapsulated cirprofloxacin as an immunotherapeutic drug
10/19/1999US5968547 Method of providing sustained analgesia with buprenorphine
10/19/1999US5968544 Acidic yogurt
10/19/1999US5968532 Substance p antagonists
10/19/1999US5968505 Compounds rich in glucosinolates such as glucoraphanin as anticarcinogenic agents, screening
10/19/1999US5968500 Bioadhesives and moisturizing mammals epithelial cells
10/19/1999US5968499 Polymeric compounds
10/19/1999US5968495 Hair sprays and conditioners
10/19/1999US5968493 Hair care composition
10/19/1999US5968487 Derivative of kojic acid and its use as a depigmenting agent
10/19/1999US5968485 UV protection compositions
10/19/1999US5968482 Radiation resistant filters for light protection of cosmetics and drugs
10/19/1999CA2197298C Novel pyrimidine derivatives and processes for the preparation thereof
10/19/1999CA2184402C Cysteic or homocysteic acid used for facilitating skin desquamation or stimulating epidermic renewal
10/19/1999CA2154913C Magnetically responsive composition for carrying biologically active substances and methods of production and use
10/19/1999CA2024612C Corticosteroid-containing ointments
10/19/1999CA2003524C Treatment of obesity
10/19/1999CA1340792C Pyrido[2,3-d]pyrimidine deratives
10/17/1999CA2269262A1 Substituted tricyclics
10/17/1999CA2269256A1 Substituted tricyclics
10/17/1999CA2268457A1 Mammalian rad1 genes, polypeptides and methods of use
10/16/1999CA2639396A1 Local delivery of rapamycin for treatment of proliferative sequelae associated with ptca procedures, including delivery using a modified stent
10/16/1999CA2639393A1 Local delivery of rapamycin for treatment of proliferative sequelae associated with ptca procedures, including delivery using a modified stent
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/16/1999CA2269046A1 Method of preventing allograft rejection
10/14/1999WO1999051751A1 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection
10/14/1999WO1999051745A2 Dna immunization against chlamydia infection
10/14/1999WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
10/14/1999WO1999051623A1 DEPRESSANT FOR PRODUCTION OF TGF-$g(b)
10/14/1999WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999WO1999051619A1 Arabinofuranosyl benzimidazoles as antiviral agents
10/14/1999WO1999051618A1 Novel crystalline forms of an antiviral benzimidazole compound
10/14/1999WO1999051617A2 FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
10/14/1999WO1999051616A1 15-membered lactams ketolides with antibacterial activity
10/14/1999WO1999051613A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051607A2 Process for purification of a cephalosporin derivative
10/14/1999WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999WO1999051604A2 Process for the production of purine derivatives
10/14/1999WO1999051602A1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them
10/14/1999WO1999051601A1 Azatricyclic compounds
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051596A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051595A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051594A1 IMIDAZO[1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS
10/14/1999WO1999051592A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
10/14/1999WO1999051591A2 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
10/14/1999WO1999051590A1 Substituted indolinones as kinase inhibitors
10/14/1999WO1999051581A1 Novel nucleic acid transfer agents, compositions containing same and uses
10/14/1999WO1999051580A1 Pyrazole inhibitors of cytokine production
10/14/1999WO1999051576A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999WO1999051575A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999WO1999051572A1 Sulfonamide derivatives
10/14/1999WO1999051571A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999WO1999051569A1 Calcilytic compounds
10/14/1999WO1999051565A1 Novel local anesthetic compounds and uses
10/14/1999WO1999051564A1 Propanolamine derivatives
10/14/1999WO1999051562A1 Novel retinoids and use thereof
10/14/1999WO1999051559A1 Anti-inflammatory, antibacterial benzyl phenol agents
10/14/1999WO1999051271A2 Compositions comprising glycol derivatives and alcohols
10/14/1999WO1999051260A2 Treatment of cardiac hypertrophy
10/14/1999WO1999051259A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
1 ... 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 ... 7860